Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples